IRIS
CANDIDO, SAVERIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.355
EU - Europa 3.078
AS - Asia 2.697
SA - Sud America 502
AF - Africa 396
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 2
Totale 12.036
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.202
SG - Singapore 1.339
RU - Federazione Russa 938
IT - Italia 936
CN - Cina 683
BR - Brasile 429
IE - Irlanda 384
VN - Vietnam 286
CI - Costa d'Avorio 215
UA - Ucraina 204
DE - Germania 170
FR - Francia 133
CA - Canada 112
KR - Corea 83
NG - Nigeria 80
IN - India 56
GB - Regno Unito 51
FI - Finlandia 48
SE - Svezia 39
BD - Bangladesh 37
SN - Senegal 37
NL - Olanda 36
MX - Messico 29
AR - Argentina 28
IQ - Iraq 28
PL - Polonia 27
TR - Turchia 27
HK - Hong Kong 25
ES - Italia 23
ZA - Sudafrica 22
CH - Svizzera 18
JP - Giappone 18
ID - Indonesia 16
PK - Pakistan 16
AT - Austria 14
UZ - Uzbekistan 13
CO - Colombia 12
IR - Iran 12
KE - Kenya 11
VE - Venezuela 10
CL - Cile 7
GR - Grecia 7
KZ - Kazakistan 7
BE - Belgio 6
BG - Bulgaria 6
CZ - Repubblica Ceca 6
JO - Giordania 6
LT - Lituania 6
NP - Nepal 6
PE - Perù 6
AU - Australia 5
BJ - Benin 5
EC - Ecuador 5
EG - Egitto 5
LB - Libano 5
MA - Marocco 5
MY - Malesia 5
SA - Arabia Saudita 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
OM - Oman 4
PT - Portogallo 4
RO - Romania 4
TN - Tunisia 4
AZ - Azerbaigian 3
BY - Bielorussia 3
CR - Costa Rica 3
DZ - Algeria 3
HR - Croazia 3
KG - Kirghizistan 3
AO - Angola 2
BO - Bolivia 2
CM - Camerun 2
ET - Etiopia 2
IL - Israele 2
MT - Malta 2
NI - Nicaragua 2
NO - Norvegia 2
SI - Slovenia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
CG - Congo 1
CU - Cuba 1
DO - Repubblica Dominicana 1
EU - Europa 1
JM - Giamaica 1
KI - Kiribati 1
KW - Kuwait 1
LI - Liechtenstein 1
LY - Libia 1
MN - Mongolia 1
MU - Mauritius 1
PA - Panama 1
PH - Filippine 1
PY - Paraguay 1
QA - Qatar 1
RS - Serbia 1
SV - El Salvador 1
Totale 12.034
Salva come PNG Salva come JPEG
Città #
Dallas 1.153
Singapore 802
Santa Clara 668
Chandler 420
Moscow 406
Dublin 376
San Jose 350
Jacksonville 278
Catania 258
Chicago 220
Ashburn 216
Abidjan 215
Boardman 151
Beijing 126
Los Angeles 109
Cambridge 100
Lawrence 100
Lauterbourg 98
Hefei 96
Andover 91
Grafing 84
Nanjing 82
Council Bluffs 81
Seoul 81
Ho Chi Minh City 80
Toronto 75
Hanoi 69
Houston 65
Des Moines 55
New York 54
Wilmington 52
Palermo 50
Dong Ket 47
Abuja 44
Civitanova Marche 43
São Paulo 38
Dakar 37
Rome 32
Buffalo 31
Columbus 30
San Mateo 30
The Dalles 28
Hebei 27
Lagos 27
Helsinki 26
Nanchang 25
Hong Kong 23
Orem 23
Saint Petersburg 22
Warsaw 21
Messina 20
Shenyang 19
Frankfurt am Main 17
Da Nang 16
Jiaxing 16
Lappeenranta 16
Milan 16
Tokyo 16
Acireale 15
Johannesburg 15
Amsterdam 14
Bremen 14
Falls Church 14
Guangzhou 14
Belo Horizonte 13
Mexico City 13
Naples 13
Rio de Janeiro 13
Dearborn 12
Montreal 12
Padova 12
Baghdad 11
Curitiba 11
Nuremberg 11
Ottawa 11
Phoenix 11
Brooklyn 10
Haiphong 10
Munich 10
Tianjin 10
Augusta 9
Chennai 9
London 9
Mumbai 9
Port Harcourt 9
Redwood City 9
Aci Catena 8
Ankara 8
Boston 8
Denver 8
Jinan 8
Kochi 8
Mascalucia 8
Nairobi 8
Norwalk 8
Poplar 8
Stockholm 8
Turin 8
Changsha 7
Erbil 7
Totale 8.184
Salva come PNG Salva come JPEG
Nome #
Gut Microbiota and Cancer: From Pathogenesis to Therapy 254
Advances in targeting signal transduction pathways. 243
Benefits and concerns of probiotics: an overview of the potential genotoxicity of the colibactin-producing Escherichia coli Nissle 1917 strain 201
Glioblastoma mesenchymal subtype enhances antioxidant defence to reduce susceptibility to ferroptosis 184
Diagnostic and Prognostic Significance of a Four-miRNA Signature in Colorectal Cancer 182
Co-Occurrence of Interleukin-6 Receptor Asp358Ala Variant and High Plasma Levels of IL-6: An Evidence of IL-6 Trans-Signaling Activation in Deep Vein Thrombosis (DVT) Patients 182
Computational modelling in melanoma for novel drug discovery 177
Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells 172
Computational identification of microRNAs associated to both epithelial to mesenchymal transition and NGAL/MMP-9 pathways in bladder cancer 167
Critical Roles of EGFR Family Members in Breast Cancer and Breast Cancer Stem Cells: Targets for Therapy 166
Analysis of the RAC1 mutations in cutaneous melanoma patients with occupational sun exposure 164
Abilities of β-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells 164
Methylation‑sensitive restriction enzyme‑droplet digital PCR assay for the one‑step highly sensitive analysis of DNA methylation hotspots 161
Droplet digital pcr analysis of liquid biopsy samples unveils the diagnostic role of hsa-mir-133a-3p and hsa-mir-375-3p in oral cancer 159
A Tailored Health Surveillance Program Unveils a Case of MALT Lymphoma in a HCV-positive Health-Care Worker 156
Bioinformatic analysis of the LCN2–SLC22A17–MMP9 network in cancer: The role of DNA methylation in the modulation of tumor microenvironment 155
Computational modeling of PI3K/AKT and MAPK signaling pathways in melanoma cancer 152
MMP-9 overexpression is associated with intragenic hypermethylation of MMP9 gene in melanoma 147
Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells 146
Ectopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural product berberine 142
Analysis of the B-RafV600E mutation in cutaneous melanoma patients with occupational sun exposure 141
Prognostic significance of deregulated microRNAs in uveal melanomas 139
EpiMethEx: a tool for large-scale integrated analysis in methylation hotspots linked to genetic regulation 137
Identification of the most common BRCA alterations through analysis of germline mutation databases: Is droplet digital PCR an additional strategy for the assessment of such alterations in breast and ovarian cancer families? 135
Identification of novel microRNAs and their diagnostic and prognostic significance in oral cancer 134
Dysregulation of IL-6 cis- and trans-signaling and high frequency of IL6R rs2228145(C>A) in the management of Deep Vein Thrombosis 133
The analysis of miRNA expression profiling datasets reveals inverse microRNA patterns in glioblastoma and Alzheimer's disease 132
Cutaneous melanoma: From pathogenesis to therapy 132
BRAF mutations in papillary thyroid carcinoma and emerging targeted therapies (review) 130
MMP-9 as a marker-of response to treatment with B-Raf inhibitors in cutaneous melanoma 129
Pericytes in microvessels: From “mural” function to brain and retina regeneration 128
DNA methylation and gene expression in melanoma: A large-scale integrated analysis 126
Analisi delle mutazioni Rac1 nei lavoratori con melanoma cutaneo esposti al sole per motivi professionali 125
Analysis of PIK3CA mutations in cutaneous melanoma patients with occupational sun exposure 125
Nitric Oxide in Hematological Cancers: Partner or Rival? 123
Emerging targeted therapies for melanoma treatment (review) 122
Identification of SLC22A17 DNA methylation hotspot as a potential biomarker in cutaneous melanoma 121
Pomegranate: A promising avenue against the most common chronic diseases and their associated risk factors (Review) 121
Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response 119
Prediction of PD‐l1 expression in neuroblastoma via computational modeling 119
Overactivation of IL6 cis‑signaling in leukocytes is an inflammatory hallmark of deep vein thrombosis 118
Role of microRNAs as novel diagnostic biomarkers and potential therapeutic targets for hearing disorders (Review) 117
microRNAs and thyroid cancer: Biological and clinical significance (Review). 111
Correlation between the overexpression of Yin Yang 1 and the expression levels of miRNAs in Burkitt's lymphoma: A computational study 111
MMP-9 as a candidate marker of response to BRAF inhibitors in melanoma patients with BRAFV600Emutation detected in circulating-free DNA 109
Environment and bladder cancer: Molecular analysis by interaction networks 107
Integrated analysis of colorectal cancer microRNA datasets: Identification of microRNAs associated with tumor development 106
Functional Roles of Matrix Metalloproteinases and Their Inhibitors in Melanoma 106
Clinical Relevance of Targeted Therapy and Immune-Checkpoint Inhibition in Lung Cancer 106
Role of Oral Microbiota Dysbiosis in the Development and Progression of Oral Lichen Planus 104
Gene alterations in the PI3K/PTEN/AKT pathway as a mechanism of drug-resistance 99
Cancer therapy and treatments during COVID-19 era 99
Role of the transcription factor Yin Yang 1 and its selectively identified target survivin in high-grade b-cells non-Hodgkin lymphomas: Potential diagnostic and therapeutic targets 99
Patient-derived tumor organoids for drug repositioning in cancer care: A promising approach in the era of tailored treatment 98
In silico analysis of the solute carrier (SLC) family in cancer indicates a link among DNA methylation, metabolic adaptation, drug response, and immune reactivity 96
Osteopontin/Matrix metalloproteinases pathway is not activated in cervical carcinoma 95
Functions of NGAL and GSK-3beta in sensitivity to targeted, chemo- and hormonal-based therapies 93
Roles of GSK-3 and microRNAs on epithelial mesenchymal transition and cancer stem cells 92
Novel insights into epigenetic regulation of il6 pathway: In silico perspective on inflammation and cancer relationship 92
Cutaneous melanoma and the immunotherapy revolution (Review) 91
Regulation of GSK-3 activity by curcumin, berberine and resveratrol: Potential effects on multiple diseases. 89
Roles of EGFR and KRAS and their downstream signaling pathways in pancreatic cancer and pancreatic cancer stem cells 86
MMP-9 is a candidate marker of response to treatment with dabrafenib in melanoma cells 86
Low levels of inflammation and the absence of subclinical atherosclerosis in rheumatoid arthritis 86
Direct oral anticoagulant treatment of deep vein thrombosis reduces IL‑6 expression in peripheral mono‑nuclear blood cells 84
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance. 84
Fluoro-edenite induces fibulin-3 overexpression in non-malignant human mesothelial cells 84
Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinases (MMPs) as biomarkers of bladder cancer development and progression 84
Effects of berberine, curcumin, resveratrol alone and in combination with chemotherapeutic drugs and signal transduction inhibitors on cancer cells-Power of nutraceuticals. 84
Low Glycemic Index Diet, Exercise and Vitamin D to Reduce Breast Cancer Recurrence: Rationale for the Design of a Clinical Trial 83
Roles of signaling pathways in drug resistance, cancer initiating cells and cancer progression and metastasis 83
Osteopontin/Matrix metalloproteinases pathway is not activated in cervical carcinoma 80
Prevalence of hepatitis C virus infection among health-care workers: A 10-year survey 79
Effects of the MDM-2 inhibitor Nutlin-3a on PDAC cells containing and lacking WT-TP53 on sensitivity to chemotherapy, signal transduction inhibitors and nutraceuticals 79
Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinases (MMPs) as biomarkers of bladder cancer development and progression 78
Overexpression of Sthamin-1 in lung cancer from patients exposed to asbestos: an "in silico" evaluation 78
Targeting signaling pathways involved in metastasis in cancer stem cells 77
Introduction of WT-TP53 into pancreatic cancer cells alters sensitivity to chemotherapeutic drugs, targeted therapeutics and nutraceuticals 77
Suppressing prostate cancer by targeting NGAL 76
Metformin influences drug sensitivity in pancreatic cancer cells 74
Overexpression of nectin like-5 is associated with a malignant phenotype in cutaneous melanoma 74
Interaction between matrix metalloproteinase-9 (MMP-9) and neutrophil gelatinase-associated lipocalin (NGAL): A recent evolutionary event in primates 74
Overexpression of Sthamin-1 is associated with the development of lung cancer developed in patients exposed to asbestos 73
Implication of IL-6 in the development of HCV-associated non-Hodgkin lymphoma 73
Roles of p53, NF-κB and the androgen receptor in controlling NGAL expression in prostate cancer cell lines 72
Detection of B-Rat mutations in ovarian cancer is associated with chemoresistance 71
Neopterin: a potential marker in chronic peripheral arterial disease 71
The tumor microenvironment in hepatocellular carcinoma 71
Targeting signaling and apoptotic pathways involved in chemotherapeutic drug-resistance of hematopoietic cells 70
Diagnostic value of neutrophil gelatinase-associated lipocalin/matrix metalloproteinase-9 pathway in transitional cell carcinoma of the bladder 70
Osteopontin/matrixmetalloproteinasis pathway activation in head and neck cancer 70
Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs 70
Drug-resistance in doxorubicin-resistant FL5.12 hematopoietic cells: elevated MDR1, drug efflux and side-population positive and decreased BCL2-family member expression 69
Effects of Ectopic Expression of NGAL on Doxorubicin Sensitivity. 69
Interactions between immune and environmental stimuli in non-Hodgkin Lymphoma 69
V600E B-Raf mutation is associated with chemoresistance in ovarian cancer 69
NUPR1, a new target in liver cancer: implication in controlling cell growth, migration, invasion and sorafenib resistance 68
Transcription analysis of Neutral Associated Lipocalin (NGAL) in Hepatocellular Carcinoma 68
Vitamin D and microRNAs: Role in the pathogenesis and prognosis of breast cancer (Review) 67
Roles of neutrophil gelatinase-associated lipocalin (NGAL) in human cancer 67
Totale 11.130
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.223
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.223
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021194 0 0 0 0 0 0 0 0 0 15 121 58
2021/2022727 62 107 5 33 102 15 100 25 52 23 21 182
2022/20231.326 114 69 30 144 118 201 11 208 321 25 56 29
2023/2024540 20 80 32 27 24 100 25 34 11 20 93 74
2024/20252.652 24 390 143 142 589 286 131 103 210 266 176 192
2025/20265.613 328 511 1.073 394 786 1.063 666 146 302 344 0 0
Totale 12.229